AllianceBernstein’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.5M | Buy |
1,518,527
+189,141
| +14% | +$5.92M | 0.02% | 613 |
|
|
2025
Q1 | $44.6M | Sell |
1,329,386
-113,794
| -8% | -$3.82M | 0.02% | 616 |
|
|
2024
Q4 | $56.6M | Buy |
1,443,180
+18,445
| +1% | +$723K | 0.02% | 559 |
|
|
2024
Q3 | $56.1M | Sell |
1,424,735
-58,431
| -4% | -$2.3M | 0.02% | 576 |
|
|
2024
Q2 | $57.8M | Buy |
1,483,166
+14,720
| +1% | +$574K | 0.02% | 561 |
|
|
2024
Q1 | $63.2M | Sell |
1,468,446
-106,122
| -7% | -$4.57M | 0.02% | 534 |
|
|
2023
Q4 | $72.5M | Buy |
1,574,568
+490,231
| +45% | +$22.6M | 0.03% | 496 |
|
|
2023
Q3 | $37M | Buy |
1,084,337
+1,018,321
| +1,543% | +$34.8M | 0.02% | 645 |
|
|
2023
Q2 | $2.54M | Sell |
66,016
-41,946
| -39% | -$1.61M | ﹤0.01% | 1769 |
|
|
2023
Q1 | $3.86M | Buy |
107,962
+51,127
| +90% | +$1.83M | ﹤0.01% | 1504 |
|
|
2022
Q4 | $2.24M | Sell |
56,835
-85,891
| -60% | -$3.39M | ﹤0.01% | 1839 |
|
|
2022
Q3 | $5.15M | Sell |
142,726
-287,234
| -67% | -$10.4M | ﹤0.01% | 1384 |
|
|
2022
Q2 | $13.1M | Buy |
429,960
+53,309
| +14% | +$1.62M | 0.01% | 1007 |
|
|
2022
Q1 | $11.5M | Buy |
376,651
+82,553
| +28% | +$2.52M | ﹤0.01% | 1140 |
|
|
2021
Q4 | $9.19M | Buy |
294,098
+30,995
| +12% | +$968K | ﹤0.01% | 1291 |
|
|
2021
Q3 | $4.02M | Buy |
263,103
+243,195
| +1,222% | +$3.72M | ﹤0.01% | 1714 |
|
|
2021
Q2 | $371K | Buy |
+19,908
| New | +$371K | ﹤0.01% | 2927 |
|